Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Digistain® logo — Digistain ® - AI risk profiling technology for hormone recep...

Digistain®

Digistain ® - AI risk profiling technology for hormone receptor-positive breast cancer.

Founded 2020 United Kingdom United Kingdom 16 employees Seed Total: $125.00K Biotechnology, Health Care +1

General Information

Company Name Digistain®
Founded Year 2020
Location United Kingdom United Kingdom +1
Employees 16
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when Digistain® moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Digistain®

Digistain is a UK-based startup that specializes in AI risk profiling technology for hormone receptor-positive breast cancer patients. The company's Digistain® is a groundbreaking digital solution for cancer diagnostics, offering dramatically faster gold standard risk scoring analytics at a lower cost. Approved by the UK's Medicines & Healthcare products Regulatory Agency (MHRA), Digistain® provides a patented risk profiling test for hormone receptor-positive breast cancer patients, based on 15 years of research and development led by respected cancer research scientists at Imperial College and Cancer Research UK. The technology offers an easy-to-read report that offers actionable information for both physicians and patients to determine the best course of treatment, including whether cytotoxic therapy is needed in addition to hormone therapy. As of 2020, the startup operates in the Biotechnology and Health Care industries, with its headquarters based in the United Kingdom. The company achieved a significant milestone with its Seed Round investment on 09 September 2021, securing funding from Acacia Venture Capital Partners. This investment reflects the industry's recognition of Digistain® and its potential to transform cancer diagnostics and treatment.

Taxonomy: cancer diagnostics, risk profiling, breast cancer, hormone receptor-positive, MHRA approved, infrared scanning, chemotherapy decision support, Imperial College, London-based startup, cancer research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
09 Sep 2021
Pre Seed Round •••••• 1
Investor
31 Aug 2021

Digistain® Alternatives & Competitors

Digistain® vs
InProTher
InProTher

InProTher is creating advanced cancer immunotherapies based on pre-clinical models with Professor Ho...

Seed
2-10 employees
Biotechnology, Health Care
Digistain® vs
San Antonio Breast Cancer Symposium
San Antonio Breast Cancer Symposium United States

An international symposium fostering interaction and exchange among leaders in breast cancer researc...

3 employees
Health Care
Digistain® vs
New York Oncology Hematology
New York Oncology Hematology United States

World class cancer care. Close to home.

206 employees
Health Care

FAQ About Digistain®

Digistain ® - AI risk profiling technology for hormone receptor-positive breast cancer.
Digistain® was founded in 2020.
Digistain® is headquartered in United Kingdom.
Digistain® operates in the following industries: Biotechnology, Health Care, Medical Devices.
Digistain® has approximately 16 employees.
Digistain® has completed 2 funding rounds, raising a total of $125.00K. The latest funding stage is Seed.
Top alternatives and competitors to Digistain® include InProTher, San Antonio Breast Cancer Symposium, New York Oncology Hematology, MeCo Diagnostics, Iovance Biotherapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Digistain® and InProTher are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Digistain® and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy